Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
The need for novel agents to treat patients with MCL who have relapsed after targeted therapy
02:21
|
Download MP3
Related Videos
5:11
iStopMM: the psychological effects of MGUS screening and changes to clinical presentation of myeloma
2:01
The evolution of BCL2 inhibition in CLL
3:08
Welcome to the Video Journal of Hematology & Hematological Oncology 🎥🩸
1:31
Frontline treatment for CLL: the changing paradigm
0:44
Early detection and interception across hematological cancers
1:59
Assessing if a patient with DLBCL is responding to treatment using PET-CT and novel assays
3:48
Trials of interest in newly diagnosed myeloma presented at IMS 2024
1:14
Promising therapies under investigation in AL amyloidosis: anti-fibril agents & bispecifics
1:13
Challenges in risk stratifying LR-MDS: insights into genetic upstaging and early transplant
1:52
A study investigating the efficacy of CAR-T therapy in Richter's transformation
1:32
Unanswered questions in MCL: when will we achieve cure?
2:22
The need for novel agents to treat patients with MCL who have relapsed after targeted therapy
4:48
The evolution of alloSCT in Richter's transformation and its combination with biological agents
2:57
Moving away from chemoimmunotherapy and towards novel targeted agents in CLL
1:20
Insights into the diagnosis of smoldering myeloma from a UK perspective & ongoing trials
1:38
The use of golcadomide in combination with R-CHOP for the treatment of aggressive B-cell lymphomas
1:36
The use of outpatient cilta-cel in the treatment of multiple myeloma
0:47
Advice for physicians when managing bispecific antibody treatment for patients with myeloma
6:54
Biomarker-guided treatment of CLL in the chemo-free era
0:51
Predicting which patients with SMM will progress to multiple myeloma
5:11 2:01 3:08 1:31 0:44 1:59 3:48 1:14 1:13 1:52 1:32 2:22 4:48 2:57 1:20 1:38 1:36 0:47 6:54 0:51
